Published January 20, 2011 | Version v1
Patent Open

INCREASED T-CELL TUMOR INFILTRATION AND ERADICATION OF METASTASES BY MUTANT LIGHT

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Mutant LIGHT expressed in a tumor environment elicited high levels of chemokines and adhesion molecules, accompanied by massive infiltration of naïve T lymphocytes. Methods and compositions to elicit immune responses against tumors including tumor volume reduction and eradication of metastasis using mutant LIGHT are disclosed.

Files

US20110014152.pdf

Files (2.5 MB)

Name Size Download all
md5:8ac712aa1bc38f5bb134b62c375a2b3a
2.5 MB Preview Download

Additional details

Identifiers

Patent application number
US 87988110 A
Patent number
US 9272025 B2
Other
oai:uchicago.tind.io:7887

Dates

Patent filed
2010-09-10

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pathology, Comprehensive Cancer Center